Position in INSM
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$5,011,140
New position
Shares Held
47,000
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#214
of 665 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026OFI INVEST ASSET MANAGEMENT holds $64,308,324 across 6 Biotechnology names. INSM ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
547,881 | $38,368,106 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,945 | $11,422,583 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,449 | $5,190,331 | |
| 4 | INSM |
INSMED Inc
This page
|
47,000 | $5,011,140 | |
| 5 | INCY |
Incyte Corp
|
37,762 | $4,280,700 | |
| 6 | LEGN |
Legend Biotech Corp
|
1,228 | $35,464 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,011,140 | 47,000 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||